Skip to content
Home/Companies/Biotech/CureVac
CureVac

CureVac

Biotech·Germany·Exited 2025·Held 20yr
Entry
2005
Hold
20yr
Exit
2025

Who owns CureVac?

CureVac is a German Biotech company, now owned by BioNTech, which acquired it in 2025 from dievini Hopp BioTech holding.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
dievini Hopp BioTech holding
Investor
dievini Hopp BioTech holding
dievini Hopp BioTech holding (Evergreen Balance Sheet) · 2005 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusAcquired
Websitewww.curevac.com
Exit Type
Trade Sale
Buyer
BioNTech
Exit Year
2025

More from dievini Hopp BioTech holding (Evergreen Balance Sheet)

Other portfolio companies in the same fund.

Heidelberg Pharma
Heidelberg Pharma
Active
BiotechGermany· 2009
Novaliq
Novaliq
Active
PharmaGermany· 2007
Immatics
Immatics
Active
BiotechGermany· 2006
Apogenix
Active
BiotechGermany· 2005
Molecular Health
Exited 2026
SaaSGermany· 2004

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns CureVac?

CureVac is now owned by BioNTech, which acquired it in 2025 from dievini Hopp BioTech holding.

When did BioNTech acquire CureVac?

BioNTech acquired CureVac in 2025, buying from dievini Hopp BioTech holding.

Who did CureVac sell to?

dievini Hopp BioTech holding sold CureVac to BioNTech in 2025 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue